Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)

Frédéric Schlemmer, Sylvie Chevret, Gwenael Lorillon, Cédric De Bazelaire, Régis Peffault de Latour, Véronique Meignin, Mauricette Michallet, Eric Hermet, Benjamin Wyplosz, Véronique Houdouin, Sylvain Marchand-Adam, Gérard Socié, Abdellatif Tazi, Anne Bergeron
European Respiratory Journal 2013 42: P2344; DOI:
Frédéric Schlemmer
1Pneumologie, Hôpital Saint Louis, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvie Chevret
2Département De Biostatistiques Et D'informatique Médicale, Hôpital Saint Louis, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gwenael Lorillon
1Pneumologie, Hôpital Saint Louis, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cédric De Bazelaire
3Radiologie, Hôpital Saint Louis, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Régis Peffault de Latour
4Hématologie Greffe, Hôpital Saint Louis, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Véronique Meignin
5Pathologie, Hôpital Saint Louis, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mauricette Michallet
6Hématologie, CHU Lyon Sud, Lyon, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eric Hermet
7Hématologie, CHU Clermont Ferrand, Clermont Ferrand, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin Wyplosz
8Médecine Interne, CHU Bicêtre, Le Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Véronique Houdouin
9Pneumo-pédiatrie, Hôpital Robert Debré, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sylvain Marchand-Adam
10Pneumologie, CHU Tours, Tours, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gérard Socié
4Hématologie Greffe, Hôpital Saint Louis, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdellatif Tazi
1Pneumologie, Hôpital Saint Louis, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne Bergeron
1Pneumologie, Hôpital Saint Louis, Paris, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Abstract

Late onset noninfectious pulmonary complications (LONIPC) following allogeneic HSCT are a frequent cause of morbidity and mortality. Although half of LONIPC have been related to infiltrative lung diseases (ILD), very few data are available in regard to their clinical characteristics. We retrospectively analysed our cohort of 40 allogeneic HSCT recipients who were diagnosed with a noninfectious ILD between 2001 and 2010. Donor hematopoietic stem cell source was peripheral blood stem cells in 75% of the cases and conditioning regimen was nonmyeloablative in 57.5%. Median time from transplant to ILD was 11.3 months [IQR: 5.9-19.2]. 82.5% of the patients had extrathoracic chronic GVHD. We identified two computed tomography (CT) scan patterns according to the predominance of ground glass opacities (n=22) or alveolar consolidations (n=18). The predominant profile of pulmonary function tests was a restrictive lung defect and bronchoalveolar lavage mainly found lymphocytic alveolitis. Histological analysis was available for 7 patients that concluded to diffuse alveolar damage, non specific interstitial pneumonia, organizing pneumonia or lymphoid interstitial pneumonia. The median follow-up after ILD diagnosis was 9.3 months (IQR: 2.1-31.75). Thirty-five patients were treated with systemic steroids for their ILD. Thirteen patients died, 10 of respiratory failure. Median survival rate at 24 months was 61 % (IQR: 45.3-82.1%). No factors were associated with survival, and no significant difference in prognosis was observed between the two lung CT patterns Further studies are needed to identify the risk factors for such complications and to evaluate the best management of these patients.

  • Interstitial lung disease
  • Immunosuppression
  • Transplantation
  • © 2013 ERS
Previous
Back to top
Vol 42 Issue Suppl 57 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Frédéric Schlemmer, Sylvie Chevret, Gwenael Lorillon, Cédric De Bazelaire, Régis Peffault de Latour, Véronique Meignin, Mauricette Michallet, Eric Hermet, Benjamin Wyplosz, Véronique Houdouin, Sylvain Marchand-Adam, Gérard Socié, Abdellatif Tazi, Anne Bergeron
European Respiratory Journal Sep 2013, 42 (Suppl 57) P2344;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Noninfectious infiltrative lung diseases after allogeneic hematopoïetic stem cell transplantation (HSCT)
Frédéric Schlemmer, Sylvie Chevret, Gwenael Lorillon, Cédric De Bazelaire, Régis Peffault de Latour, Véronique Meignin, Mauricette Michallet, Eric Hermet, Benjamin Wyplosz, Véronique Houdouin, Sylvain Marchand-Adam, Gérard Socié, Abdellatif Tazi, Anne Bergeron
European Respiratory Journal Sep 2013, 42 (Suppl 57) P2344;
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension
  • Usual interstitial pneumonia preceding rheumatoid arthritis: Clinical, imaging, and histopathologic features
  • Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Show more 1.5 Diffuse Parenchymal Lung Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society